SGLT2 Inhibitors Rescue Lysosomal mTORC1 Hyperactivity and Proximal Tubulopathy in Preclinical Models of Cystinosis
Svenja Aline Keller, Patrick Krohn, Zhiyong Chen, Alessandro Luciani, Olivier Devuyst
This study shows SGLT2 inhibitors reduce mTORC1 hyperactivity and proximal tubulopathy in cystinosis models by altering lysosomal metabolism, independent of cystine clearance.
bioRxiv · Feb 3, 2026 · PreprintPathology